ArticleJACC. Case reports2025
Cardiogenic Shock Patient Found to Have Cardiac Amyloidosis and Concurrent Multiple Myeloma.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiac amyloidosis is an under-recognized cause of heart failure. CASE SUMMARY: A 61-year-old man presented with acute decompensated heart failure and cardiogenic shock requiring peripheral venoarterial extracorporeal membrane oxygenation support. Endomyocardial biopsy revealed a diagnosis of light-chain cardiac amyloidosis. Work-up for incidentally noted hypercalcemia also revealed a rare diagnosis of concurrent multiple myeloma. Unfortunately, the patient clinically deteriorated with limited treatment options and ultimately died in hospital. DISCUSSION: We discuss this case in relation to the complexities of recognizing and making a diagnosis of cardiac amyloidosis as well as the atypical presentation with cardiogenic shock and concurrent multiple myeloma. TAKE-HOME MESSAGES: A broad differential diagnosis is required in patients with heart failure and worsening cardiogenic shock, including under-recognized etiologies such as cardiac amyloidosis. Though rare, cardiac amyloidosis can co-occur with multiple myeloma, and making the diagnosis early is important to inform available treatment options.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.